サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1552663

経口固形製剤の世界市場：産業分析、規模、シェア、成長、動向、予測、2024-2034年

Oral Solid Dosage Pharmaceutical Formulation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

出版日
ページ情報
英文 167 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
経口固形製剤の世界市場：産業分析、規模、シェア、成長、動向、予測、2024-2034年
出版日: 2024年07月15日
発行: Transparency Market Research
ページ情報: 英文 167 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

経口固形製剤市場- 調査範囲

TMRの調査レポート「経口固形製剤の世界市場」は、2024年から2034年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2024年を基準年、2034年を予測年として、2018年から2034年までの世界の経口固形製剤市場の収益と予測を提供しています。また、2024年から2034年までの世界の経口固形製剤市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されています。1次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、主要企業の製品資料、アニュアルレポート、プレスリリース、関連資料などを参照し、経口固形製剤市場を推察しました。

市場スナップショット
2023年の市場規模 6億5,460万米ドル
2034年の市場規模 11億米ドル
CAGR 5.2%

当レポートでは、世界の経口固形製剤市場の競合情勢について調査しています。世界の経口固形製剤市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイルされています。企業概要、財務状況、最近の動向、SWOTなどが、本レポートで紹介されている世界の経口固形製剤市場におけるプレイヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 市場分析と予測、2020-2034年

第5章 主要洞察

  • パイプライン分析
  • 主要製品・ブランド分析
  • 主要M&A
  • COVID-19による産業への影響

第6章 世界の市場分析と予測：剤形別

  • イントロダクションと定義
  • 主な調査結果・発展
  • 市場金額予測：剤形別、2020-2034年
    • 錠剤
      • 従来型/即時放出
      • 調節放出
      • チュアブル錠
      • 発泡錠
    • カプセル
      • ハードゼラチンカプセル
      • ソフトゼラチンカプセル
    • 粉末
    • ロゼンジ・トローチ
    • グミ
  • 市場の魅力分析：剤形別

第7章 世界の市場分析と予測：薬物放出メカニズム別

  • イントロダクションと定義
  • 主な調査結果・発展
  • 市場金額予測：薬物放出メカニズム別、2020-2034年
    • 即時放出
    • 遅延放出
    • 制御放出
  • 市場の魅力分析：薬物放出メカニズム別

第8章 世界の市場分析と予測：流通チャネル別

  • イントロダクションと定義
  • 主な調査結果・発展
  • 市場金額予測：流通チャネル別、2020-2034年
    • 病院薬局
    • 小売薬局
    • オンライン薬局
  • 市場の魅力分析：流通チャネル別

第9章 世界の市場分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別、2020-2034年
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力分析：地域別

第10章 北米の市場分析と予測

第11章 欧州の市場分析と予測

第12章 アジア太平洋地域の市場分析と予測

第13章 ラテンアメリカの市場分析と予測

第14章 中東・アフリカの市場分析と予測

第15章 競合情勢

  • 市場企業- 競争マトリックス（企業階層と規模別）
  • 市場シェア分析：企業別（2023）
  • 企業プロファイル
    • AstraZeneca plc
    • Bristol-Myers Squibb Company
    • Eli Lilly and Company
    • Gilead Sciences, Inc.
    • Merck & Co. Inc.
    • Novartis AG
    • Pfizer Inc.
    • AbbVie Inc.
    • Boehringer Ingelheim GmbH
    • F. Hoffmann-La Roche Ltd.
    • Johnson & Johnson
    • Biogen Inc.
    • Bayer AG
    • Teva Pharmaceutical Industries Ltd.
    • Amgen Inc.
    • Takeda Pharmaceutical Company
    • Otsuka Pharmaceutical Co., Ltd.
図表

List of Tables

  • Table 01: Global Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Dosage Form, 2020-2034
  • Table 02: Global Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Drug Release Mechanism, 2020-2034
  • Table 03: Global Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 04: Global Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Region, 2020-2034
  • Table 05: North America Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Country, 2020-2034
  • Table 06: North America Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Dosage Form, 2020-2034
  • Table 07: North America Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Drug Release Mechanism, 2020-2034
  • Table 08: North America Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 09: Europe Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 10: Europe Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Dosage Form, 2020-2034
  • Table 11: Europe Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Drug Release Mechanism, 2020-2034
  • Table 12: Europe Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 13: Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 14: Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Dosage Form, 2020-2034
  • Table 15: Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Drug Release Mechanism, 2020-2034
  • Table 16: Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 17: Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 18: Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Dosage Form, 2020-2034
  • Table 19: Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Drug Release Mechanism, 2020-2034
  • Table 20: Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 21: Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Dosage Form, 2020-2034
  • Table 23: Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Drug Release Mechanism, 2020-2034
  • Table 24: Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034

List of Figures

  • Figure 01: Global Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2034
  • Figure 02: Global Oral Solid Dosage Pharmaceutical Formulation Market Revenue (US$ Mn), by Dosage Form, 2023
  • Figure 03: Global Oral Solid Dosage Pharmaceutical Formulation Market Value Share, by Dosage Form, 2023
  • Figure 04: Global Oral Solid Dosage Pharmaceutical Formulation Market Revenue (US$ Mn), by Drug Release Mechanism, 2023
  • Figure 05: Global Oral Solid Dosage Pharmaceutical Formulation Market Value Share, by Drug Release Mechanism, 2023
  • Figure 06: Global Oral Solid Dosage Pharmaceutical Formulation Market Revenue (US$ Mn), by Distribution Channel, 2023
  • Figure 07: Global Oral Solid Dosage Pharmaceutical Formulation Market Value Share, by Distribution Channel, 2023
  • Figure 08: Global Oral Solid Dosage Pharmaceutical Formulation Market Value Share, by Region, 2023
  • Figure 09: Global Oral Solid Dosage Pharmaceutical Formulation Market Value (US$ Mn) Forecast, 2020-2034
  • Figure 10: Global Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Dosage Form, 2023 and 2034
  • Figure 11: Global Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 12: Global Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Drug Release Mechanism, 2023 and 2034
  • Figure 13: Global Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Drug Release Mechanism, 2024-2034
  • Figure 14: Global Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 15: Global Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 16: Global Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 17: Global Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 18: North America Oral Solid Dosage Pharmaceutical Formulation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 19: North America Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 20: North America Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 21: North America Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Dosage Form, 2023 and 2034
  • Figure 22: North America Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Drug Release Mechanism, 2023 and 2034
  • Figure 23: North America Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 24: North America Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 25: North America Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Drug Release Mechanism, 2024-2034
  • Figure 26:North America Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 27: Europe Oral Solid Dosage Pharmaceutical Formulation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 28: Europe Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 29: Europe Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 30: Europe Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Dosage Form, 2023 and 2034
  • Figure 31: Europe Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Drug Release Mechanism, 2023 and 2034
  • Figure 32: Europe Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 33: Europe Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 34: Europe Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Drug Release Mechanism, 2024-2034
  • Figure 35: Europe Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 36: Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 37: Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 38: Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 39: Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Dosage Form, 2023 and 2034
  • Figure 40: Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Drug Release Mechanism, 2023 and 2034
  • Figure 41: Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 42: Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 43: Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Drug Release Mechanism, 2024-2034
  • Figure 44: Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 45: Latin America Oral Solid Dosage Pharmaceutical Formulation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 46: Latin America Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 47: Latin America Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 48: Latin America Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Dosage Form, 2023 and 2034
  • Figure 49: Latin America Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Drug Release Mechanism, 2023 and 2034
  • Figure 50: Latin America Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 51: Latin America Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 52: Latin America Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Drug Release Mechanism, 2024-2034
  • Figure 53: Latin America Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 54: Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 55: Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 56: Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 57: Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Dosage Form, 2023 and 2034
  • Figure 58: Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Drug Release Mechanism, 2023 and 2034
  • Figure 59: Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 60: Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 61: Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Drug Release Mechanism, 2024-2034
  • Figure 62: Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Distribution Channel, 2024-2034
目次
Product Code: TMRGL80675

Oral Solid Dosage Pharmaceutical Formulation Market - Scope of Report

TMR's report on the global oral solid dosage pharmaceutical formulation market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global oral solid dosage pharmaceutical formulation market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global oral solid dosage pharmaceutical formulation market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the oral solid dosage pharmaceutical formulation market.

Market Snapshot
Market Value in 2023US$ 654.6 Mn
Market Value in 2034US$ 1.1 Bn
CAGR5.2%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global oral solid dosage pharmaceutical formulation market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global oral solid dosage pharmaceutical formulation market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global oral solid dosage pharmaceutical formulation market.

The report delves into the competitive landscape of the global oral solid dosage pharmaceutical formulation market. Key players operating in the global oral solid dosage pharmaceutical formulation market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global oral solid dosage pharmaceutical formulation market profiled in this report.

Key Questions Answered in Global oral solid dosage pharmaceutical formulation Market Report:

  • What is the sales/revenue generated by oral solid dosage pharmaceutical formulation across all regions during the forecast period?
  • What are the opportunities in the global oral solid dosage pharmaceutical formulation market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Oral Solid Dosage Pharmaceutical Formulation Market - Research Objectives and Research Approach

The comprehensive report on the global oral solid dosage pharmaceutical formulation market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global oral solid dosage pharmaceutical formulation market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global oral solid dosage pharmaceutical formulation market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Oral Solid Dosage Pharmaceutical Formulation Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecast, 2020-2034

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product /Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecast, by Dosage Form

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Dosage Form, 2020-2034
    • 6.3.1. Tablets
      • 6.3.1.1. Conventional/Immediate Release
      • 6.3.1.2. Modified Release
      • 6.3.1.3. Chewable Tablets
      • 6.3.1.4. Effervescent Tablets
    • 6.3.2. Capsules
      • 6.3.2.1. Hard Gelatin Capsules
      • 6.3.2.2. Soft Gelatin Capsules
    • 6.3.3. Powders
    • 6.3.4. Lozenges & Pastilles
    • 6.3.5. Gummies
  • 6.4. Market Attractiveness Analysis, by Dosage Form

7. Global Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecast, by Drug Release Mechanism

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Drug Release Mechanism, 2020-2034
    • 7.3.1. Immediate Release
    • 7.3.2. Delayed Release
    • 7.3.3. Controlled Release
  • 7.4. Market Attractiveness Analysis, by Drug Release Mechanism

8. Global Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecast, by Distribution Channel

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Distribution Channel, 2020-2034
    • 8.3.1. Hospital Pharmacies
    • 8.3.2. Retail Pharmacies
    • 8.3.3. Online Pharmacies
  • 8.4. Market Attractiveness Analysis, by Distribution Channel

9. Global Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2020-2034
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Market Value Forecast, by Dosage Form, 2020-2034
    • 10.3.1. Tablets
      • 10.3.1.1. Conventional/Immediate Release
      • 10.3.1.2. Modified Release
      • 10.3.1.3. Chewable Tablets
      • 10.3.1.4. Effervescent Tablets
    • 10.3.2. Capsules
      • 10.3.2.1. Hard Gelatin Capsules
      • 10.3.2.2. Soft Gelatin Capsules
    • 10.3.3. Powders
    • 10.3.4. Lozenges & Pastilles
    • 10.3.5. Gummies
  • 10.4. Market Value Forecast, by Drug Release Mechanism, 2020-2034
    • 10.4.1. Immediate Release
    • 10.4.2. Delayed Release
    • 10.4.3. Controlled Release
  • 10.5. Market Value Forecast, by Distribution Channel, 2020-2034
    • 10.5.1. Hospital Pharmacies
    • 10.5.2. Retail Pharmacies
    • 10.5.3. Online Pharmacies
  • 10.6. Market Value Forecast, by Country, 2020-2034
    • 10.6.1. U.S.
    • 10.6.2. Canada
  • 10.7. Market Attractiveness Analysis
    • 10.7.1. By Dosage Form
    • 10.7.2. By Drug Release Mechanism
    • 10.7.3. By Distribution Channel
    • 10.7.4. By Country

11. Europe Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Key Findings
  • 11.3. Market Value Forecast, by Dosage Form, 2020-2034
    • 11.3.1. Tablets
      • 11.3.1.1. Conventional/Immediate Release
      • 11.3.1.2. Modified Release
      • 11.3.1.3. Chewable Tablets
      • 11.3.1.4. Effervescent Tablets
    • 11.3.2. Capsules
      • 11.3.2.1. Hard Gelatin Capsules
      • 11.3.2.2. Soft Gelatin Capsules
    • 11.3.3. Powders
    • 11.3.4. Lozenges & Pastilles
    • 11.3.5. Gummies
  • 11.4. Market Value Forecast, by Drug Release Mechanism, 2020-2034
    • 11.4.1. Immediate Release
    • 11.4.2. Delayed Release
    • 11.4.3. Controlled Release
  • 11.5. Market Value Forecast, by Distribution Channel, 2020-2034
    • 11.5.1. Hospital Pharmacies
    • 11.5.2. Retail Pharmacies
    • 11.5.3. Online Pharmacies
  • 11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 11.6.1. Germany
    • 11.6.2. U.K.
    • 11.6.3. France
    • 11.6.4. Italy
    • 11.6.5. Spain
    • 11.6.6. Rest of Europe
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Dosage Form
    • 11.7.2. By Drug Release Mechanism
    • 11.7.3. By Distribution Channel
    • 11.7.4. By Country/Sub-region

12. Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Key Findings
  • 12.3. Market Value Forecast, by Dosage Form, 2020-2034
    • 12.3.1. Tablets
      • 12.3.1.1. Conventional/Immediate Release
      • 12.3.1.2. Modified Release
      • 12.3.1.3. Chewable Tablets
      • 12.3.1.4. Effervescent Tablets
    • 12.3.2. Capsules
      • 12.3.2.1. Hard Gelatin Capsules
      • 12.3.2.2. Soft Gelatin Capsules
    • 12.3.3. Powders
    • 12.3.4. Lozenges & Pastilles
    • 12.3.5. Gummies
  • 12.4. Market Value Forecast, by Drug Release Mechanism, 2020-2034
    • 12.4.1. Immediate Release
    • 12.4.2. Delayed Release
    • 12.4.3. Controlled Release
  • 12.5. Market Value Forecast, by Distribution Channel, 2020-2034
    • 12.5.1. Hospital Pharmacies
    • 12.5.2. Retail Pharmacies
    • 12.5.3. Online Pharmacies
  • 12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 12.6.1. China
    • 12.6.2. Japan
    • 12.6.3. India
    • 12.6.4. Australia & New Zealand
    • 12.6.5. Rest of Asia Pacific
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Dosage Form
    • 12.7.2. By Drug Release Mechanism
    • 12.7.3. By Distribution Channel
    • 12.7.4. By Country/Sub-region

13. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Key Findings
  • 13.3. Market Value Forecast, by Dosage Form, 2020-2034
    • 13.3.1. Tablets
      • 13.3.1.1. Conventional/Immediate Release
      • 13.3.1.2. Modified Release
      • 13.3.1.3. Chewable Tablets
      • 13.3.1.4. Effervescent Tablets
    • 13.3.2. Capsules
      • 13.3.2.1. Hard Gelatin Capsules
      • 13.3.2.2. Soft Gelatin Capsules
    • 13.3.3. Powders
    • 13.3.4. Lozenges & Pastilles
    • 13.3.5. Gummies
  • 13.4. Market Value Forecast, by Drug Release Mechanism, 2020-2034
    • 13.4.1. Immediate Release
    • 13.4.2. Delayed Release
    • 13.4.3. Controlled Release
  • 13.5. Market Value Forecast, by Distribution Channel, 2020-2034
    • 13.5.1. Hospital Pharmacies
    • 13.5.2. Retail Pharmacies
    • 13.5.3. Online Pharmacies
  • 13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 13.6.1. Brazil
    • 13.6.2. Mexico
    • 13.6.3. Rest of Latin America
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Dosage Form
    • 13.7.2. By Drug Release Mechanism
    • 13.7.3. By Distribution Channel
    • 13.7.4. By Country/Sub-region

14. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecast

  • 14.1. Introduction
  • 14.2. Key Findings
  • 14.3. Market Value Forecast, by Dosage Form, 2020-2034
    • 14.3.1. Tablets
      • 14.3.1.1. Conventional/Immediate Release
      • 14.3.1.2. Modified Release
      • 14.3.1.3. Chewable Tablets
      • 14.3.1.4. Effervescent Tablets
    • 14.3.2. Capsules
      • 14.3.2.1. Hard Gelatin Capsules
      • 14.3.2.2. Soft Gelatin Capsules
    • 14.3.3. Powders
    • 14.3.4. Lozenges & Pastilles
    • 14.3.5. Gummies
  • 14.4. Market Value Forecast, by Drug Release Mechanism, 2020-2034
    • 14.4.1. Immediate Release
    • 14.4.2. Delayed Release
    • 14.4.3. Controlled Release
  • 14.5. Market Value Forecast, by Distribution Channel, 2020-2034
    • 14.5.1. Hospital Pharmacies
    • 14.5.2. Retail Pharmacies
    • 14.5.3. Online Pharmacies
  • 14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 14.6.1. GCC Countries
    • 14.6.2. South Africa
    • 14.6.3. Rest of Middle East & Africa
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Dosage Form
    • 14.7.2. By Drug Release Mechanism
    • 14.7.3. By Distribution Channel
    • 14.7.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2023)
  • 15.3. Company Profiles
    • 15.3.1. AstraZeneca plc
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Financial Overview
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Bristol-Myers Squibb Company
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Financial Overview
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Eli Lilly and Company
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Financial Overview
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Gilead Sciences, Inc.
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Financial Overview
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Merck & Co. Inc.
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Financial Overview
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Novartis AG
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Financial Overview
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Pfizer Inc.
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Financial Overview
      • 15.3.7.5. Strategic Overview
    • 15.3.8. AbbVie Inc.
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Financial Overview
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Boehringer Ingelheim GmbH
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. SWOT Analysis
      • 15.3.9.4. Financial Overview
      • 15.3.9.5. Strategic Overview
    • 15.3.10. F. Hoffmann-La Roche Ltd.
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. SWOT Analysis
      • 15.3.10.4. Financial Overview
      • 15.3.10.5. Strategic Overview
    • 15.3.11. Johnson & Johnson
      • 15.3.11.1. Company Overview
      • 15.3.11.2. Product Portfolio
      • 15.3.11.3. SWOT Analysis
      • 15.3.11.4. Financial Overview
      • 15.3.11.5. Strategic Overview
    • 15.3.12. Biogen Inc.
      • 15.3.12.1. Company Overview
      • 15.3.12.2. Product Portfolio
      • 15.3.12.3. SWOT Analysis
      • 15.3.12.4. Financial Overview
      • 15.3.12.5. Strategic Overview
    • 15.3.13. Bayer AG
      • 15.3.13.1. Company Overview
      • 15.3.13.2. Product Portfolio
      • 15.3.13.3. SWOT Analysis
      • 15.3.13.4. Financial Overview
      • 15.3.13.5. Strategic Overview
    • 15.3.14. Teva Pharmaceutical Industries Ltd.
      • 15.3.14.1. Company Overview
      • 15.3.14.2. Product Portfolio
      • 15.3.14.3. SWOT Analysis
      • 15.3.14.4. Financial Overview
      • 15.3.14.5. Strategic Overview
    • 15.3.15. Amgen Inc.
      • 15.3.15.1. Company Overview
      • 15.3.15.2. Product Portfolio
      • 15.3.15.3. SWOT Analysis
      • 15.3.15.4. Financial Overview
      • 15.3.15.5. Strategic Overview
    • 15.3.16. Takeda Pharmaceutical Company
      • 15.3.16.1. Company Overview
      • 15.3.16.2. Product Portfolio
      • 15.3.16.3. SWOT Analysis
      • 15.3.16.4. Financial Overview
      • 15.3.16.5. Strategic Overview
    • 15.3.17. Otsuka Pharmaceutical Co., Ltd.
      • 15.3.17.1. Company Overview
      • 15.3.17.2. Product Portfolio
      • 15.3.17.3. SWOT Analysis
      • 15.3.17.4. Financial Overview
      • 15.3.17.5. Strategic Overview